维拉科技
VCYT
43.12
-1.27
-2.86%
维拉科技
US · VCYT
#2330 按市值排名
上市于 1970
43.12
-1.27
-2.86%
实时 - 追踪5344个代码 - 心跳于268秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了3家。
- 机构持股总比例下降了1.0个百分点。
机构持股
- 机构持股比例
- 111.18% -1.02pp
- 机构数量
- 441 -3
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund99.94%
Hedge Fund3.94%
Public Company3.85%
Government Pension Fund1.63%
Private Company0.72%
Individual/Insider0.59%
Insurance Company0.50%
VC/PE Fund0.34%
Sovereign Wealth Fund0.12%
主要股东 截至 2026-06-30
BlackRock
16.78% · 13.49M 股
FMR
9.58% · 7.70M 股
Artisan Partners Limited Partnership
6.89% · 5.54M 股
Vanguard Portfolio Management, LLC
5.87% · 4.72M 股
State Street Global Advisors
5.84% · 4.70M 股
Vanguard Capital Management, LLC
5.17% · 4.16M 股
Dimensional Fund Advisors
3.52% · 2.83M 股
First Trust Advisors L.P.
3.12% · 2.51M 股
ARK Investment Management LLC
2.86% · 2.30M 股
Wellington Management Group
2.83% · 2.27M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 15次买入 · 35次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Marc Stapley | Chief Executive Officer | 0.20% |
| Robert Epstein | Independent Chairperson | 0.07% |
| Eliav Barr | Independent Director | 0.06% |
| Muna Bhanji | Independent Director | 0.05% |
| Rebecca Chambers | Chief Financial Officer | 0.05% |
| Evan Jones | Independent Director | 0.04% |
| Phillip Febbo | Chief Scientific & Medical Officer | 0.03% |
| Jens Holstein | Independent Director | 0.03% |
| Thomas Miller | Director | 0.02% |
| David Shafer | Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-23 | Jens Holstein | Independent Director | Intent to Sell (Form 144) | -7,500 | $47.00 |
| 2026-09-20 | John Leite | Chief Commercial Officer for CLIA Business | Automatic Disposition | -4,015 | $40.00 |
| 2026-09-13 | Jens Holstein | Independent Director | Automatic Disposition | -5,000 | $40.95 |
| 2026-09-03 | Phillip Febbo | Chief Scientific & Medical Officer | Open Market Disposition | -13,110 | $42.89–43.66 |
| 2026-09-03 | Rebecca Chambers | Chief Financial Officer | Open Market Disposition | -3,652 | $42.81–43.71 |
| 2026-09-03 | Annie McGuire | Executive VP, General Counsel & Chief People Officer | Open Market Disposition | -3,254 | $42.79–43.67 |
| 2026-09-01 | Phillip Febbo | Chief Scientific & Medical Officer | Sale to Issuer | -3,639 | $44.88 |
| 2026-09-01 | Marc Stapley | Chief Executive Officer | Sale to Issuer | -8,782 | $44.88 |
| 2026-09-01 | Jonathan Wygant | Vice President | Sale to Issuer | -1,361 | $44.88 |
| 2026-09-01 | Rebecca Chambers | Chief Financial Officer | Sale to Issuer | -3,603 | $44.88 |
| 2026-09-01 | John Leite | Chief Commercial Officer for CLIA Business | Sale to Issuer | -3,961 | $44.88 |
| 2026-09-01 | Annie McGuire | Executive VP, General Counsel & Chief People Officer | Sale to Issuer | -3,215 | $44.88 |
| 2026-08-31 | Muna Bhanji | Independent Director | Automatic Disposition | -1,864 | $42.97 |
| 2026-06-17 | Karin Eastham | Independent Director | Automatic Disposition | -3,729 | $52.78–53.55 |
| 2026-06-10 | Karin Eastham | Independent Director | Other Acquisition | +5,272 | -- |
| 2026-06-10 | Evan Jones | Independent Director | Other Acquisition | +5,272 | -- |
| 2026-06-10 | Robert Epstein | Independent Chairperson | Other Acquisition | +5,272 | -- |
| 2026-06-10 | Jens Holstein | Independent Director | Other Acquisition | +5,272 | -- |
| 2026-06-10 | David Shafer | Director | Other Acquisition | +5,272 | -- |
| 2026-06-10 | Muna Bhanji | Independent Director | Other Acquisition | +5,272 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
维拉科技 讨论区 0 条评论